![The Fuzzy Factor: Striving to Protect Patient Privacy in Big Data Sets](https://www.aacr.org/wp-content/uploads/2017/08/data-art-380x265.jpg)
The Fuzzy Factor: Striving to Protect Patient Privacy in Big Data Sets
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...
Recently, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic vemurafenib (Zelboraf) for treating certain adults...
This past year has been a year of many “firsts” for the oncology community, with several revolutionary advances in...
In 2018, we witnessed significant momentum in several hot areas of cancer research, including immunotherapy and precision medicine. Researchers...
There has been a rapid expansion of technology in recent years, from artificial intelligence to intensive genetic sequencing to...
In the past couple of decades, progress against cancer has created a new generation of survivors. Today, more than...
In 2019, research continued to drive progress across the spectrum of cancer care in the form of new and...
As the COVID-19 pandemic swept the globe this spring, the American Association for Cancer Research (AACR) launched a major...
In an extraordinary turn of events, the American Association for Cancer Research (AACR) Annual Meeting 2020 kicked off Monday...
Just over a month ago, the American Association for Cancer Research (AACR) held the first portion of its Annual...
The AACR Annual Meeting 2021 featured the theme “Discovery Science Driving Clinical Breakthroughs.” Indeed, over the course of two weeks,...
This year marks the 10th anniversary of Cancer Discovery, a journal of the AACR. To celebrate the anniversary, Cancer Discovery published a special anniversary issue, featured spotlights on groundbreaking articles on its website, and held the Cancer Discovery ...
The American Association for Cancer Research (AACR) is pleased to announce the Call for Abstracts for the AACR Annual...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
Progress against cancer has been fueled not by a single discipline or a sole blockbuster discovery, but by incremental...
At the age of 40, Marlena Murphy was diagnosed with triple-negative breast cancer, an aggressive subtype that occurs twice...
From a joyous opening performance from the Preservation Hall All-Stars to a closing plenary that highlighted the full spectrum...
Guest post by Hisham Hamadeh, PhD, and Shawn M. Sweeney, PhD Imagine a world where many of the decisions...
Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems...
Insights from the AACR Cancer Disparities Progress Report 2024.
A recap of the plenary sessions, cutting-edge science, clinical trials, and more covered by the AACR blog.
The Global Scholar Alumni Committee reflects on their progress after the first year in helping the careers of young...